Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis
Clinical trial NCT03594981 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03594981
- Sponsor
- Catherine Bollard
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-24
- Primary completion
- 2026-11-05
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.